The Epithelial Sodium Channel Is a Modifier of the Long‐Term Nonprogressive Phenotype Associated with F508del CFTR Mutations
暂无分享,去创建一个
Meghan C Towne | M. Bamshad | M. Emond | T. Louie | M. Matthay | Jiahai Shi | M. Towne | P. Agrawal | Ruobing Wang | C. Simone-Roach | C. Gerard | N. Gerard | S. Sheng | T. Kleyman | H. L. Li | Jingxin Chen | C. F. Brainson | Carla F. Kim | K. Schmitz-Abe | Shaohu Sheng
[1] C. Korbmacher,et al. δβγ-ENaC is inhibited by CFTR but stimulated by cAMP in Xenopus laevis oocytes. , 2017, American journal of physiology. Lung cellular and molecular physiology.
[2] N. Joo,et al. Marked increases in mucociliary clearance produced by synergistic secretory agonists or inhibition of the epithelial sodium channel , 2016, Scientific Reports.
[3] Mugdha Joshi,et al. Mutations in the substrate binding glycine-rich loop of the mitochondrial processing peptidase-α protein (PMPCA) cause a severe mitochondrial disease , 2016, Cold Spring Harbor molecular case studies.
[4] M. Rieder,et al. Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis , 2015, PLoS genetics.
[5] B. Tümmler,et al. Origins of cystic fibrosis lung disease. , 2015, The New England journal of medicine.
[6] George Havenith,et al. Cystic Fibrosis: Lessons from the Sweat Gland , 2015 .
[7] Bonnie F. Sloane,et al. Cathepsin B contributes to Na+ hyperabsorption in cystic fibrosis airway epithelial cultures , 2014, The Journal of physiology.
[8] M. Welsh,et al. Neonates with cystic fibrosis have a reduced nasal liquid pH; a small pilot study. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[9] Matthias Schoenberger,et al. Novel Small Molecule Epithelial Sodium Channel Inhibitors as Potential Therapeutics in Cystic Fibrosis ‐ a Patent Evaluation , 2014 .
[10] R. Tarran,et al. Does epithelial sodium channel hyperactivity contribute to cystic fibrosis lung disease? , 2013, The Journal of physiology.
[11] S. Donaldson,et al. New pulmonary therapies directed at targets other than CFTR. , 2013, Cold Spring Harbor perspectives in medicine.
[12] S. Sheng,et al. Gain-of-function variant of the human epithelial sodium channel. , 2013, American journal of physiology. Renal physiology.
[13] H. Sticht,et al. A mutation in the β-subunit of ENaC identified in a patient with cystic fibrosis-like symptoms has a gain-of-function effect. , 2013, American journal of physiology. Lung cellular and molecular physiology.
[14] S. Matalon,et al. δ ENaC: a novel divergent amiloride-inhibitable sodium channel. , 2012, American journal of physiology. Lung cellular and molecular physiology.
[15] M. Drumm,et al. The influence of genetics on cystic fibrosis phenotypes. , 2012, Cold Spring Harbor perspectives in medicine.
[16] M. Rieder,et al. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. , 2012, American journal of human genetics.
[17] S. Matalon,et al. Characterization of a novel splice variant of δ ENaC subunit in human lungs. , 2012, American journal of physiology. Lung cellular and molecular physiology.
[18] M. Welsh,et al. Reduced Airway Surface pH Impairs Bacterial Killing in the Porcine Cystic Fibrosis Lung , 2012, Nature.
[19] B. Blobner,et al. Extracellular Finger Domain Modulates the Response of the Epithelial Sodium Channel to Shear Stress* , 2012, The Journal of Biological Chemistry.
[20] Tian-Le Xu,et al. Highly Conserved Salt Bridge Stabilizes Rigid Signal Patch at Extracellular Loop Critical for Surface Expression of Acid-sensing Ion Channels* , 2012, The Journal of Biological Chemistry.
[21] M. Drumm,et al. Genetic variation and clinical heterogeneity in cystic fibrosis. , 2012, Annual review of pathology.
[22] T. Kleyman,et al. ENaC structure and function in the wake of a resolved structure of a family member. , 2011, American journal of physiology. Renal physiology.
[23] Fred A. Wright,et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2 , 2011, Nature Genetics.
[24] C I Amos,et al. Evolutionary evidence of the effect of rare variants on disease etiology , 2011, Clinical genetics.
[25] M. Corey,et al. TLR5 as an Anti-Inflammatory Target and Modifier Gene in Cystic Fibrosis , 2010, The Journal of Immunology.
[26] M. Welsh,et al. Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia , 2010, Cell.
[27] G. Cutting. Modifier genes in Mendelian disorders: the example of cystic fibrosis , 2010, Annals of the New York Academy of Sciences.
[28] J. Adelman,et al. Constraint-based, Homology Model of the Extracellular Domain of the Epithelial Na+ Channel α Subunit Reveals a Mechanism of Channel Activation by Proteases* , 2010, The Journal of Biological Chemistry.
[29] E. Elkin,et al. Year-to-year changes in lung function in individuals with cystic fibrosis. , 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[30] K. L. Winarski,et al. Extracellular Allosteric Regulatory Subdomain within the γ Subunit of the Epithelial Na+ Channel* , 2010, The Journal of Biological Chemistry.
[31] D. Kentrup,et al. Characterization of the epithelial sodium channel delta-subunit in human nasal epithelium. , 2010, American journal of respiratory cell and molecular biology.
[32] J. Todd,et al. Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes , 2009, Science.
[33] T. Joh,et al. Epithelial Na+ channel delta subunit is an acid sensor in the human oesophagus. , 2008, European journal of pharmacology.
[34] F. Echeverri,et al. Small Molecule Activator of the Human Epithelial Sodium Channel* , 2008, Journal of Biological Chemistry.
[35] Mark M Iles,et al. What Can Genome-Wide Association Studies Tell Us about the Genetics of Common Disease , 2008, PLoS genetics.
[36] J. Yankaskas,et al. Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. , 2007, The Journal of pediatrics.
[37] R. Boucher. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. , 2007, Annual review of medicine.
[38] M. Myerburg,et al. Airway Surface Liquid Volume Regulates ENaC by Altering the Serine Protease-Protease Inhibitor Balance , 2006, Journal of Biological Chemistry.
[39] S. Matalon,et al. δ-Subunit Confers Novel Biophysical Features to αβγ-Human Epithelial Sodium Channel (ENaC) via a Physical Interaction* , 2006, Journal of Biological Chemistry.
[40] N. Joo,et al. Hyposecretion, Not Hyperabsorption, Is the Basic Defect of Cystic Fibrosis Airway Glands*♦ , 2006, Journal of Biological Chemistry.
[41] D. Ussery,et al. The TNFα receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis , 2006, Human Genetics.
[42] Michael R Knowles,et al. Genetic modifiers of lung disease in cystic fibrosis. , 2005, The New England journal of medicine.
[43] R. Boucher,et al. Evaluation of Second Generation Amiloride Analogs as Therapy for Cystic Fibrosis Lung Disease , 2004, Journal of Pharmacology and Experimental Therapeutics.
[44] Richard C Boucher,et al. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice , 2004, Nature Medicine.
[45] John P. Johnson,et al. Epithelial Sodium Channels Are Activated by Furin-dependent Proteolysis* , 2004, Journal of Biological Chemistry.
[46] S. Batalov,et al. A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[47] S. Shimada,et al. Protons Activate the δ-Subunit of the Epithelial Na+ Channel in Humans* , 2004, Journal of Biological Chemistry.
[48] J. B. Bruns,et al. Extracellular Histidine Residues Crucial for Na+ Self-inhibition of Epithelial Na+ Channels* , 2004, Journal of Biological Chemistry.
[49] S. Matalon,et al. Mutations in the extracellular loop of alpha-rENaC alter sensitivity to amiloride and reactive species. , 2004, American journal of physiology. Renal physiology.
[50] S. Shimada,et al. Protons activate the delta-subunit of the epithelial Na+ channel in humans. , 2004, The Journal of biological chemistry.
[51] S. Gründer,et al. A New Subunit of the Epithelial Na+ Channel Identifies Regions Involved in Na+ Self-inhibition* , 2003, Journal of Biological Chemistry.
[52] S. Sheng,et al. External Nickel Inhibits Epithelial Sodium Channel by Binding to Histidine Residues within the Extracellular Domains of α and γ Subunits and Reducing Channel Open Probability* , 2002, The Journal of Biological Chemistry.
[53] L. Schild,et al. An External Site Controls Closing of the Epithelial Na+ Channel ENaC , 2002, The Journal of physiology.
[54] R. Boucher. Pathogenesis of cystic fibrosis airways disease. , 1999, Transactions of the American Clinical and Climatological Association.
[55] M. Welsh,et al. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[56] H. Garty,et al. Epithelial sodium channels: function, structure, and regulation. , 1997, Physiological reviews.
[57] M. Lazdunski,et al. Molecular Cloning and Functional Expression of a Novel Amiloride-sensitive Na+ Channel (*) , 1995, The Journal of Biological Chemistry.
[58] J C Olsen,et al. CFTR as a cAMP-dependent regulator of sodium channels , 1995, Science.
[59] M. Lazdunski,et al. Functional Degenerin-containing Chimeras Identify Residues Essential for Amiloride-sensitive Na Channel Function (*) , 1995, The Journal of Biological Chemistry.
[60] J. Zieleński,et al. Cystic fibrosis: genotypic and phenotypic variations. , 1995, Annual review of genetics.
[61] L. Schild,et al. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits , 1994, Nature.
[62] G. Cutting,et al. Cystic fibrosis transmembrane conductance regulator and the etiology and pathogenesis of cystic fibrosis , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[63] M. King,et al. Aerosolized amiloride as treatment of cystic fibrosis lung disease: a pilot study. , 1991, Advances in experimental medicine and biology.
[64] A. L. Goldin. Expression of ion channels by injection of mRNA into Xenopus oocytes. , 1991, Methods in cell biology.
[65] M. King,et al. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. , 1990, The New England journal of medicine.